Recent Faculty Publications

Our division’s prolific researchers publish their findings in the world’s most influential cardiology and cardiovascular medicine journals.

Michael Cain, MD, FAHA, FACC, FHRS

Neelamegham S, Canty JM. (2024) Anemia, Increased Shear Stress, and the Progression of Aortic Stenosis. JACC. Basic to translational science (Feb), 9(2): 200-202. doi:10.1016/j.jacbts.2023.12.002
Sherpa MD, Sonkawade SD, Jonnala V, Pokharel S, Khazaeli M, Yatsynovich Y, Kalot MA, Weil BR, Canty JM, Sharma UC. (2023) Galectin-3 Is Associated with Cardiac Fibrosis and an Increased Risk of Sudden Death. Cells (Apr), 12(9). doi:10.3390/cells12091218
Techiryan G, Weil BR, Young RF, Canty JM. (2022) Widespread Intracoronary Allogeneic Cardiosphere-Derived Cell Therapy With and Without Cyclosporine in Reperfused Myocardial Infarction. American journal of physiology. Heart and circulatory physiology (Sep).

Ahmed A, Wilkoff BL, Kim JA, Nabutovsky Y, Kim G, Desmond M, Ganz L, Curtis AB. (2024) Comparing complication rates between Abbott Tendril 2088 and competitive manufacturer leads: Novel real-world data approach. Journal of cardiovascular electrophysiology (Dec), 35(12): 2305-2311. doi:10.1111/jce.16437
Oates CP, Jackson LR, Young R, Chiswell K, Curtis AB, Piccini JP, Reddy VY, Whang W. (2024) Impact of race and ethnicity on the rhythm control of newly diagnosed atrial fibrillation: Insights from the Get With the Guidelines Atrial Fibrillation Registry. Heart rhythm (Nov).
Sudesh S, Abraham WT, Cleland JGF, Curtis AB, Friedman DJ, Gold MR, Kutyifa V, Linde C, Tang AS, Olivas-Martinez A, Inoue LYT, Sanders GD, Al-Khatib SM. (2024) Cardiac Resynchronization Therapy in Ischemic Versus Nonischemic Cardiomyopathy: Patient-Level Meta-Analysis of 7 Randomized Clinical Trials. JACC. Heart failure (Nov), 12(11): 1915-1924.

Das Pradhan A, Glynn RJ, Fruchart JC, MacFadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ, Brinton EA, Eckel RH, Elam MB, Felicio JS, Ginsberg HN, Goudev A, Ishibashi S, Joseph J, Kodama T, Koenig W, Leiter LA, Lorenzatti AJ, Mankovsky B, Marx N, Nordestgaard BG, Páll D, Ray KK, Santos RD, Soran H, Susekov A, Tendera M, Yokote K, Paynter NP, Buring JE, Libby P, Ridker PM, . (2022) Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk. The New England journal of medicine (Nov), 387(21): 1923-1934.
Malhotra S, Singh V, Fallavollita JA, Canty JM. (2022) Letter to the Editor. Myocardial Denervation and Left Ventricular Volume Predict Ventricular Arrhythmias in Patients With Ischemic Cardiomyopathy. JACC. Cardiovascular imaging (Jun), 15(6): 1164-1166.

Brady CT, Marshall A, Eagler LA, Pon TM, Duffey ME, Weil BR, Lang JK, Parker MD. (2024) Left Ventricular Systolic Dysfunction in NBCe1-B/C-Knockout Mice. International journal of molecular sciences (Sep), 25(17). doi:10.3390/ijms25179610
Mentkowski KI, Tarvirdizadeh T, Manzanero CA, Eagler LA, Lang JK. (2024) Surface engineering enhances the therapeutic potential of systemically delivered extracellular vesicles following acute myocardial infarction. FASEB journal : official publication of the Federation of American Societies for Experimental Biology (Sep), 38(18): e70070. doi:10.1096/fj.202400828R
Xu Y, Ying L, Lang JK, Hinz B, Zhao R. (2024) Modeling mechanical activation of macrophages during pulmonary fibrogenesis for targeted anti-fibrosis therapy. Science advances (Mar), 10(13): eadj9559. doi:10.1126/sciadv.adj9559

Nepali S, Chen M, Karthikeyan B, Sonkawade SD, Mahajan SD, Spernyak J, Sharma UC, Pokharel S. (2025) Claudin 1 dysregulation disrupts coronary microvascular integrity and impairs cardiac function. Atherosclerosis (Apr), 403: 119149.
Rolland TJ, Hudson ER, Graser LA, Zahra S, Cucinotta D, Sonkawade SD, Sharma UC, Weil BR. (2025) Mitochondrial DNA-Mediated Immune Activation After Resuscitation from Cardiac Arrest. medRxiv : the preprint server for health sciences (Feb). doi:10.1101/2025.02.14.25322318
Sharma UC, Pokharel S. (2025) Letter to the Editor. TAVR in cancer patients: outcomes in survivors with radiation and active cancer. Cardio-oncology (London, England) (Feb), 11(1): 19. doi:10.1186/s40959-025-00301-0